A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia

KANAI M.; MORITA S.; MATSUMOTO S.; NISHIMURA T.; HATANO E.; YAZUMI S.; SASAKI T.; YASUDA H.; KITANO T.; MISAWA A.; ISHIGURO H.; YANAGIHARA K.; IKAI I.; DOI R.; FUKUSHIMA M.

Art

J-GLOBAL ID：200902292434668169 Reference number：09A0925227

A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia

ゲムシタビンにより誘発される好中球減少症の発生と喫煙歴は逆相関する

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=09A0925227&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A0925227&from=J-GLOBAL&jstjournalNo=W0107A") }}

Author (15)： , , , , , , , , , , , , , ,
Material：
Volume： 20 Issue： 8 Page： 1397-1401 Publication year： Aug. 2009
JST Material Number： W0107A ISSN： 0923-7534 CODEN： ANONE2 Document type： Article
Article type：原著論文 Country of issue： United Kingdom (GBR) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A0925227&from=J-GLOBAL&jstjournalNo=W0107A") }}

Tobacco(=cigarette) , Blood cell tumors(=neoplasms) , Clinical oncology in general , Basic research of antitumor(=antineoplastic)drugs , Blood tests(=hematologic tests)

Reference (21)：

Burris HA III, Moore MJ, Andersen J et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15: 2403-2413.
Sandler AB, Nemunaitis J, Denham C et al. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 2000; 18: 122-130.
Gebbia V, Giuliani F, Maiello E et al. Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. J Clin Oncol 2001; 19: 4089-4091.
von der Maase H, Hansen SW, Roberts JT et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 2000; 18: 3068-3077.
Rothenberg ML, Moore MJ, Cripps MC et al. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol 1996; 7: 347-353.

ｍore...

, , , ,

Return to Previous Page